Open-label Study of Dupilumab in Patients With Atopic Dermatitis

Clinical trial NCT01949311 · COMPLETED

Trial details

NCT number: NCT01949311
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2013-10-10
Primary completion: 2022-06-27
Enrollment: 2733

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.